We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QADA
3101
DELISTED
QAD Inc.
QADA
| $1.29M | ﹤0.01% |
14,787
-1,302
| -8% | -$95K |
|
3102
Archrock
AROC
$5.9B
| $1.28M | ﹤0.01% |
146,046
-2,918
| -2% | -$27.2K |
|
3103
Heron Therapeutics
HRTX
$95.4M
| $1.28M | ﹤0.01% |
82,587
+17,316
| +27% | +$275K |
|
|
AAMI
3104
Acadian Asset Management
AAMI
$3.27B
| $1.28M | ﹤0.01% |
54,318
+4,809
| +10% | +$109K |
|
|
ENDP
3105
DELISTED
Endo International plc
ENDP
| – | – |
-212,724
| Closed | -$1.22M |
|
3106
JELD-WEN Holding
JELD
$158M
| $1.27M | ﹤0.01% |
48,105
-8,808
| -15% | -$249K |
|
3107
Aurinia Pharmaceuticals
AUPH
$2.06B
| $1.27M | ﹤0.01% |
97,975
-68,108
| -41% | -$868K |
|
3108
Sibanye-Stillwater
SBSW
$7.03B
| $1.27M | ﹤0.01% |
76,336
+33,156
| +77% | +$615K |
|
3109
TTM Technologies
TTMI
$14.6B
| $1.27M | ﹤0.01% |
88,680
-7,797
| -8% | -$116K |
|
3110
Gray Television
GTN
$462M
| $1.27M | ﹤0.01% |
54,479
-26,517
| -33% | -$575K |
|
3111
Designer Brands
DBI
$339M
| $1.27M | ﹤0.01% |
77,847
-36,957
| -32% | -$651K |
|
3112
PUT
Dell
DELL
$286B
| $1.27M | ﹤0.01% |
+24,465
| New | +$1.23M |
|
|
REML
3113
DELISTED
Credit Suisse X-Links Monthly Pay 2xLeveraged Mortgage REIT ETN
REML
| $1.27M | ﹤0.01% |
168,734
| – | – |
|
3114
CALL
First Majestic Silver
AG
$8.54B
| $1.26M | ﹤0.01% |
80,000
-170,000
| -68% | -$2.83M |
|
3115
Preferred Bank
PFBC
$1.25B
| $1.26M | ﹤0.01% |
19,998
+2,787
| +16% | +$185K |
|
3116
Astec Industries
ASTE
$1.04B
| $1.26M | ﹤0.01% |
20,088
-2,811
| -12% | -$196K |
|
|
FRG
3117
DELISTED
Franchise Group, Inc.
FRG
| $1.26M | ﹤0.01% |
35,756
+1,521
| +4% | +$56K |
|
|
PRO
3118
DELISTED
PROS Holdings
PRO
| $1.26M | ﹤0.01% |
26,864
-11,317
| -30% | -$501K |
|
3119
Establishment Labs
ESTA
$2.47B
| $1.26M | ﹤0.01% |
+14,402
| New | +$1.07M |
|
3120
US Physical Therapy
USPH
$1.15B
| $1.26M | ﹤0.01% |
10,901
+1,175
| +12% | +$135K |
|
|
ALX
3121
Alexander's
ALX
$1.41B
| $1.25M | ﹤0.01% |
4,673
-50
| -1% | -$13.8K |
|
3122
iShares MSCI Australia ETF
EWA
$1.44B
| $1.25M | ﹤0.01% |
47,945
-600
| -1% | -$15.8K |
|
3123
iShares Biotechnology ETF
IBB
$9.48B
| $1.25M | ﹤0.01% |
7,607
-29,554
| -80% | -$4.55M |
|
3124
Mesa Laboratories
MLAB
$568M
| $1.25M | ﹤0.01% |
4,588
+14
| +0.3% | +$3.55K |
|
|
AMWD
3125
DELISTED
American Woodmark
AMWD
| $1.24M | ﹤0.01% |
15,203
-2,154
| -12% | -$202K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.